A share price of Moderna Inc [MRNA] is currently trading at $29.46, down -0.57%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MRNA shares have gain 6.35% over the last week, with a monthly amount glided 10.30%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Moderna Inc [NASDAQ: MRNA] stock has seen the most recent analyst activity on December 12, 2025, when Jefferies initiated its Hold rating and assigned the stock a price target of $30. Previously, Citigroup started tracking the stock with Neutral rating on March 13, 2025, and set its price target to $40. On February 18, 2025, downgrade downgraded it’s rating to Equal Weight and revised its price target to $45 on the stock. Goldman downgraded its rating to a Neutral and decreased its price target to $51 on January 29, 2025. Argus downgraded its rating to a Hold. In a note dated November 19, 2024, Berenberg initiated a Hold rating and provided a target price of $42 on this stock.
Moderna Inc experienced fluctuations in its stock price throughout the past year between $22.28 and $48.92. Currently, Wall Street analysts expect the stock to reach $29.27 within the next 12 months. Moderna Inc [NASDAQ: MRNA] shares were valued at $29.46 at the most recent close of the market. An investor can expect a potential drop of -0.64% based on the average MRNA price forecast.
Analyzing the MRNA fundamentals
Trailing Twelve Months sales for Moderna Inc [NASDAQ:MRNA] were 2.23B which represents -45.44% decline. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -1.56%, Pretax Profit Margin comes in at -1.42%, and Net Profit Margin reading is -1.4%. To continue investigating profitability, this company’s Return on Assets is posted at -0.26, Equity is -0.31 and Total Capital is -0.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.09 points at the first support level, and at 28.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.13, and for the 2nd resistance point, it is at 30.80.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Moderna Inc [NASDAQ:MRNA] is 3.93. Also, the Quick Ratio is 3.73, while the Cash Ratio stands at 0.67. Considering the valuation of this stock, the price to sales ratio is 5.16, the price to book ratio is 1.23.
Transactions by insiders
Recent insider trading involved Flagship Pioneering Inc., Affiliate, that happened on Dec 11 ’25 when 23853.0 shares were purchased. Director, Hussain Abbas completed a deal on Dec 09 ’25 to sell 504.0 shares. Meanwhile, Director Hussain Abbas bought 504.0 shares on Dec 09 ’25.
